Medican Enterprises Announces Zoning Approval for Marijuana Business Operations in 67,000 Square Foot Arizona Property
25 Février 2015 - 2:00PM
Business Wire
Medican Enterprises Inc.
(OTCBB:MDCN), announced today that the 67,000 square foot facility
located, in Phoenix Arizona, it is acquiring has received zoning
approval and is now zone compliant for the operation of legal
medical marijuana businesses.
“With the zoning approval in hand, this commercial transaction
now meets our criteria and we are moving rapidly to finalize the
due diligence process,” commented Ken Williams, CEO of Medican
Enterprises. “Located just minutes from Hwy 60 and the I-17 and
featuring excellent visibility in a high traffic center, this
unique property represents the type of asset we are looking
for.”
The transaction is planned for closure by the end of the first
quarter of 2015.
About Medican Enterprises, Inc.
Medican Enterprises is a company seeking promising
pharmaceutical and other business opportunities in the emerging
medical and recreational marijuana sector. Through its
subsidiaries, Medican is seeking to invest in businesses associated
with the growing, marketing, research and development, training,
distribution and retail sale of medical and recreational marijuana,
both in the United States and Canada. For more information visit:
www.medicaninc.com.
Cautionary Note Regarding Forward-Looking Statements
This press release and statements of representatives of Medican
Enterprises, Inc. (the “Company”) related thereto includes
forward-looking statements within the meaning of the U.S. federal
securities laws. Forward looking statements are statements that are
not historical facts. Such forward-looking statements are subject
to significant risks and uncertainties that are subject to change
based on various factors (many of which are beyond the Company's
control), which could cause actual results to differ from the
forward looking statements. Such statements may include, without
limitation, statements with respect to the Company's plans,
objectives, projections, expectations and intentions and other
statements identified by words such as "projects," "may," "will,"
"could," "would," "should," "believes," "expects," "anticipates,"
"estimates," "intends," "plans," "potential" or similar
expressions. These statements are based upon the current beliefs
and expectations of the Company's management but are subject to
significant risks and uncertainties, including those detailed in
the Company's filings with the Securities and Exchange Commission.
Actual results (including, without limitation, the results of the
Company’s efforts to acquire and integrate the dispensary property
as described herein) may differ from those set forth in the
forward-looking statements. Except as required by applicable law,
the Company expressly disclaims any obligations or undertaking to
release publicly any updates or revisions to any forward-looking
statements contained herein to reflect any change in the Company’s
expectations with respect thereto or any change in events,
conditions or circumstances on which any statement is based.
Medican Enterprises Inc.Ken Williams,
+1.800.416.8802CEOinvestors@medicaninc.com
Medican Enterprises (PK) (USOTC:MDCN)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Medican Enterprises (PK) (USOTC:MDCN)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024